Surrogate markers aid lung cancer trials

Research suggests that surrogate markers for overall survival are acceptable endpoints for clinical trials of chemotherapy and radiotherapy in patients with lung cancer.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news